In Segment A, members will acquire distinct doses and schedules of oral ABBV-744 tablet to establish Secure dosing routine. Additional individuals are going to be enrolled in the determined monotherapy dosign program. In Phase B, members will acquire oral ruxolitinib and ABBV-744 will probably be supplied as "add-on" therapy. In https://abbv-744inacutemyeloidleu58913.rimmablog.com/31430555/the-smart-trick-of-abbv-744-preclinical-studies-and-results-that-nobody-is-discussing